FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
FDA批准摘要:瑞波替尼用于治疗局部晚期或转移性ROS1阳性非小细胞肺癌
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-0949
Barbato, Michael I; Bradford, Diana; Ren, Yi; Aungst, Stephanie L; Miller, Claudia P; Pan, Lili; Zirkelbach, Jeanne F; Li, Yangbing; Bi, Youwei; Fan, Jianghong; Grimstein, Manuela; Dorff, Sarah E; Amatya, Anup K; Mishra-Kalyani, Pallavi S; Scepura, Barbara; Schotland, Peter; Udoka, Opeyemi; Ojofeitimi, Idara; Leighton, John K; Rahman, Nam A; Pazdur, Richard; Singh, Harpreet; Kluetz, Paul G; Drezner, Nicole